ORTEXORTEX News
Tracking PATK? Get live short interest, options flow, and signals on ORTEX.Sign up free →
PA
Earnings PreviewPATK

PATK Short Sellers Pull Back Even as Analyst Targets Keep Falling

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 27 Oct 2026, 04:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Patrick Industries added 6.1% over the past week to $70.46, a move that stands out sharply against a peer group that was essentially flat. Closest comparable LCII gained 7.3%, but GNTX dropped 1.1% and ALV shed 1.0%, making the PATK and LCII combination the only meaningful outperformers in the group. The stock reports Q3 results on October 29.

Short interest remains elevated at 17% of free float, roughly 5.7 million shares. That figure jumped more than 32% over the past month, a notable build that left shorts sitting on a position that has now moved against them as the stock bounced. The ORTEX short score stands at 72.7, placing PATK in the 5th percentile by short score rank versus the broader universe, meaning the short setup is more intense here than at nearly all its peers. Despite all of this, the lending market is not tight: availability has widened sharply this week, now running at 238.5% (more than twice as many shares available to borrow as are currently borrowed), up from 147.6% a week ago. Borrowing costs are also modest at 0.52%. That combination, high short interest with loose borrow conditions, suggests shorts are not under pressure to cover on mechanical grounds.

Analysts have maintained positive ratings throughout 2026 but have been cutting targets consistently. Truist Securities lowered its target to $88 from $108 on October 23, just days before the print, while keeping a Buy. BMO Capital trimmed to $100 from $120 on October 13, also maintaining Outperform. Keybanc made a similar move earlier in the month. Every major note this year has pointed in one direction on the target, downward, even as ratings have held. The mean consensus target is now $99, implying roughly 40% upside to the current price, but the trajectory of cuts makes that headline figure a less reliable anchor than it appears. The core disagreement is straightforward: those constructive on PATK point to execution through a difficult RV cycle, a 500 basis point gross margin improvement versus 2019, and the strategic logic of the pending LCII merger with its estimated $150 million of cost synergies. Those more cautious flag lower RV and manufactured housing shipment assumptions, management's reduced operating cash flow guidance of $320 million to $350 million, and elevated customer concentration, with Thor and Berkshire Hathaway representing 28% of 2025 consolidated sales.

Options positioning has flipped noticeably toward call exposure. The put/call ratio dropped to 0.43, nearly 1.8 standard deviations below its 20-day average of 0.65. That is the most call-heavy reading in several weeks, a reversal from a period in early October when the PCR was running above 0.79. Options traders appear to be positioning for continuation of the recent bounce rather than protection against a miss.

ORTEX forecasts that the pending acquisition of LCII, once closed, puts an 84% probability on a share count increase in the Russell 2000 and Russell 3000, and an 80% chance in the S&P SmallCap 600, based on the enlarged share base the combined company would carry. These are forecasts, not confirmed changes; the estimated effective date is June 30, 2027. The October 29 print is therefore as much a read on whether management can hold margins and cashflow guidance through the deal uncertainty as it is a straight revenue test.

Stocks in this article

See the live data behind this article on ORTEX.

Open PATK on ORTEX →

How this article was generated

Generated
27 Oct 2026, 04:49
Data as of
27 Oct 2026, 04:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.